MedSales Network Blog
Careers, Hiring, and What’s Changing Now

Abbott announced FDA clearance and CE Mark for Ultreon™ 3.0, combining OCT coronary imaging with AI-driven insights for PCI. Here is what the news signals for interventional cardiology sales teams and hiring managers in 2026.

AI is quietly becoming a competitive advantage in medical device sales. Here’s how the top 1% of reps are using it to close more deals, build stronger relationships, and outperform their peers in 2026.

Medtronic’s acquisition of CathWorks signals a major shift toward AI-driven cardiovascular care. Here’s what it means for medical device sales reps and the future of interventional cardiology.

Abbott is doubling down on diagnostics, rapid testing, and early detection technologies in 2026. Here’s how this shift is creating new opportunities—and new expectations—for medical device sales reps.

From AI diagnostics to robotic surgery expansions, the latest medtech press releases reveal where the industry is heading—and where the biggest sales opportunities are emerging.

AI-enabled devices, robotics expansions, and faster FDA approvals are reshaping medical sales in 2026. Here’s how new technology launches are creating fresh opportunities for reps.